Test filters

News

In the media

Press releases

Publications

Scientific articles

Statements

Stories

Videos

Viewpoints

In the media

26 Mar 2026

Un golpe de efecto para acabar con la enfermedad del sueño: “Aspiramos a eliminar el trastorno en 2030”

El Mundo

In the media

2 Apr 2026

La milagrosa cura de la enfermedad del sueño

RTVE

Stories

Lab lessons that matter: Pharmacy students help bridge the gap in research for neglected diseases

Stories

16 Apr 2026

One dose, one cure

Scientific articles

14 Apr 2026

Translational Pharmacokinetic-Pharmacodynamic Modeling and Efficacious Human Dose Prediction of DNDI-6148 for the Treatment of Cutaneous Leishmaniasis

Clinical and Translational Science

In the media

11 Apr 2026

Face à la dengue, la recherche s’active alors que le réchauffement laisse craindre une saison 2026 record

Le Monde

Scientific articles

27 Mar 2026

Prognostic models predicting clinical outcomes in patients diagnosed with visceral leishmaniasis: a systematic review

BMJ Public Health

News

31 Mar 2026

DNDi is looking for a Board Treasurer to join its Board of Directors

In the media

26 Mar 2026

Boron plays a key role in new sleeping sickness drug

Chemistry World

Videos

26 Mar 2026

Manufacturing medicines for NTDs, with Dr Stephen Robinson

Scientific articles

14 Jan 2026

(Un)intended consequences: a social sciences stocktake of a decade of Global Action Plan-inspired antimicrobial governance

The Lancet Microbe

Scientific articles

24 Mar 2026

The burden of eumycetoma in Africa: a neglected fungal disease

The Lancet Regional Health – Africa

Statements

23 Mar 2026

DNDi statement at the sixth meeting of the Intergovernmental Working Group (IGWG) on the WHO Pandemic Agreement

In the media

18 Mar 2026

RD Congo : Un nouveau traitement contre la maladie du sommeil

TV5Monde

News

16 Mar 2026

A new drug could be the beginning of the end for sleeping sickness

NPR

News

16 Mar 2026

The Best Weapon Yet Against Sleeping Sickness

Science

International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Un golpe de efecto para acabar con la enfermedad del sueño: “Aspiramos a eliminar el trastorno en 2030”

La milagrosa cura de la enfermedad del sueño

Lab lessons that matter: Pharmacy students help bridge the gap in research for neglected diseases

One dose, one cure

Translational Pharmacokinetic-Pharmacodynamic Modeling and Efficacious Human Dose Prediction of DNDI-6148 for the Treatment of Cutaneous Leishmaniasis

Face à la dengue, la recherche s’active alors que le réchauffement laisse craindre une saison 2026 record

Prognostic models predicting clinical outcomes in patients diagnosed with visceral leishmaniasis: a systematic review

DNDi is looking for a Board Treasurer to join its Board of Directors

Boron plays a key role in new sleeping sickness drug

Manufacturing medicines for NTDs, with Dr Stephen Robinson

(Un)intended consequences: a social sciences stocktake of a decade of Global Action Plan-inspired antimicrobial governance

The burden of eumycetoma in Africa: a neglected fungal disease

DNDi statement at the sixth meeting of the Intergovernmental Working Group (IGWG) on the WHO Pandemic Agreement

RD Congo : Un nouveau traitement contre la maladie du sommeil

A new drug could be the beginning of the end for sleeping sickness

The Best Weapon Yet Against Sleeping Sickness

Learn more

Get in touch

Support us

Work with us